Invus Public Equities, L.P. 13D and 13G filings for GlycoMimetics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2024-11-12 4:30 pm Sale |
2024-09-30 | 13G | GlycoMimetics, Inc. GLYC |
Invus Public Equities, L.P. | 1,965,114 3.000% |
-3,323,394![]() (-62.84%) |
Filing |
2024-08-15 5:01 pm Sale |
2024-08-13 | 13G | GlycoMimetics, Inc. GLYC |
Invus Public Equities, L.P. | 5,288,508 8.200% |
-3,300,556![]() (-38.43%) |
Filing |
2024-07-29 7:24 pm Purchase |
2024-07-25 | 13G | GlycoMimetics, Inc. GLYC |
Invus Public Equities, L.P. | 8,589,064 13.300% |
8,589,064![]() (New Position) |
Filing |